Morning Market Losers

shares dropped 27.75% to $19.51 after the company 7:07 announced results from Phase 2b clinical trial evaluating tenapanor in treating Hyperphosphatemia in chronic kidney disease patients on Hemodialysis.

shares fell 17.32% to $3.15 after the company reported Q3 results and announced the suspension of common unit distribution.

shares slipped 11.56% to $3.29 after the company announced significant new finding from its Phase I/II muscle injury trial.

shares declined 9.88% to $21.61 after the company reported Q4 earnings of $0.51 per share and announced a $100 million buyback.

shares fell 8.61% to $37.17 after the company issued a weak 2014 outlook and projected 2015 earnings of $1.95 to $2.20 per share.

declined 5.65% to $11.18. NV5 Holdings reported that it has acquired program management consulting firm Joslin, Lesser & Associates.

shares slipped 2.51% to $38.19 after the company reported reported in-line earnings for the fiscal second quarter and announced its plans to sell US Foods facilities to Performance Food Group related to its pending merger with US Foods..